User profiles for "author:M Montorfano"
 | Matteo MontorfanoInterventional Cardiology Unit, IRCCS Ospedale San Raffaele, Milan, Italy Verified email at hsr.it Cited by 25204 |
[HTML][HTML] Multi-organ point-of-care ultrasound for COVID-19 (PoCUS4COVID): international expert consensus
…, CB Laursen, F Lee, R Liu, M Meineri, M Montorfano… - Critical care, 2020 - Springer
COVID-19 has caused great devastation in the past year. Multi-organ point-of-care
ultrasound (PoCUS) including lung ultrasound (LUS) and focused cardiac ultrasound …
ultrasound (PoCUS) including lung ultrasound (LUS) and focused cardiac ultrasound …
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
ContextTraditionally, stent thrombosis has been regarded as a complication of percutaneous
coronary interventions during the first 30 postprocedural days. However, delayed …
coronary interventions during the first 30 postprocedural days. However, delayed …
Procedural strategies to reduce the incidence of contrast-induced acute kidney injury during percutaneous coronary intervention
Contrast-induced acute kidney injury (CI-AKI) is a potentially serious complication following
coronary angiography and percutaneous coronary intervention (PCI). The incidence of CI …
coronary angiography and percutaneous coronary intervention (PCI). The incidence of CI …
ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes
As of March 31, 2020 (median follow-up, 13 days; interquartile range, 2–20 days), 11
patients (39.3%) had died, 1 (3.6%) was still hospitalized in an intensive care unit, and 16 …
patients (39.3%) had died, 1 (3.6%) was still hospitalized in an intensive care unit, and 16 …
Renal Insufficiency following contrast media administration trial (REMEDIAL) A randomized comparison of 3 preventive strategies
…, N Morici, A Focaccio, I Michev, M Montorfano… - Circulation, 2007 - Am Heart Assoc
Background—Volume supplementation by saline infusion combined with N-acetylcysteine
(NAC) represents an effective strategy to prevent contrast agent–induced nephrotoxicity …
(NAC) represents an effective strategy to prevent contrast agent–induced nephrotoxicity …
Early and mid-term results of drug-eluting stent implantation in unprotected left main
…, E Bonizzoni, E Tsagalou, I Iakovou, M Montorfano… - Circulation, 2005 - Am Heart Assoc
Background—The safety and efficacy of percutaneous coronary intervention in unprotected
left main (ULM) coronary arteries are still a matter of debate. Methods and Results—All …
left main (ULM) coronary arteries are still a matter of debate. Methods and Results—All …
Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment
…, C Godino, G Melzi, I Michev, M Montorfano… - Circulation, 2007 - Am Heart Assoc
Background—The need for prolonged aspirin and thienopyridine therapy and the risk of
stent thrombosis (ST) remain as drawbacks associated with drug-eluting stents. Methods …
stent thrombosis (ST) remain as drawbacks associated with drug-eluting stents. Methods …
Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post …
…, I Michev, GM Sangiorgi, M Montorfano… - Journal of the American …, 2005 - jacc.org
Objectives: The purpose of this research was to evaluate the long-term outcomes after
implantation of drug-eluting stents (DES) in bifurcation lesions with the “crush” technique …
implantation of drug-eluting stents (DES) in bifurcation lesions with the “crush” technique …
Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction
…, A Castelli, M Mussardo, M Montorfano… - Journal of the American …, 2009 - jacc.org
Objectives: Atorvastatin administered at least 7 days before the percutaneous coronary
intervention (PCI) reduces the rate of periprocedural myocardial infarction (MI). It is unknown …
intervention (PCI) reduces the rate of periprocedural myocardial infarction (MI). It is unknown …
Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience
…, F Maisano, E Bonizzoni, J Cosgrave, M Montorfano… - Circulation, 2006 - Am Heart Assoc
Background—Improvements in results with percutaneous coronary intervention (PCI) with
drug-eluting stents (DES) may extend their use in patients with left main coronary artery …
drug-eluting stents (DES) may extend their use in patients with left main coronary artery …